Patent · US Active

Compositions comprising PCSK9-binding molecules and methods of use

US10738102B2 · kind B2 · utility

2Cited by

3References

30Claims

0Family size

Assignee

LIB Therapeutics, Inc. · US

Inventors

Tracy S. Mitchell · Andover, US
Richard Mealey · Cincinnati, US

Key dates

Filing date	Sep 20, 2019
Grant date	Aug 11, 2020
Priority date	—
Expiry date	Sep 20, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/74
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure provides pharmaceutical compositions comprising fibronectin based scaffold domain proteins that bind, for example, proprotein convertase subtilisin kexin-9 (PCSK9).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.